Bright Minds Biosciences DRUG Income Statement (2019-2026)

NASDAQ DRUG
$66.94 -1.08 (-1.58%)
As of: Sep 4, 2026 · 11:12 AM EDT
Reported Financials

Bright Minds Biosciences Quarterly Income Statement

Periods 25 quarters
Latest Jun 2026

Bright Minds Biosciences reported net income of -$1.73M for the quarter ended Jun 2026. This income statement covers 25 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Cost of RevenueCost of Rev
0.01M0.08M0.07M0.01M0.03M0.03M0.07M0.01M0.03M0.05M0.07M0.01M0.02M0.03M0.08M0.01M0.09M0.11M0.03M0.02M
Operating items
Research & DevelopmentR&D
1.75M3.05M2.96M1.61M1.95M1.08M1.03M0.78M0.81M0.90M0.08M-0.41M0.30M0.75M1.79M1.94M3.48M4.06M9.51M6.69M
Selling, General & AdministrativeSG&A
0.07M0.17M0.06M0.07M0.08M0.05M0.10M0.09M-0.03M0.05M0.04M0.06M0.04M0.06M0.19M0.12M0.19M0.25M0.55M0.29M
Operating ExpensesOpex
1.83M3.22M3.01M1.68M2.03M1.12M1.14M0.87M0.78M0.95M0.12M-0.35M0.34M0.80M1.98M2.06M3.67M4.31M10.06M6.97M
Operating IncomeOp. Inc
-1.09M-1.24M0.16M0.03M
EBIT
-1.09M-5.50M-1.24M1.25M0.16M-2.08M0.03M2.35M4.31M-9.99M-6.01M-9.59M-3.75M
Non-operating items
Interest & Investment IncomeInt & Inv Inc
0.01M0.00M0.00M0.35M0.34M0.38M0.59M1.96M2.02M
Other Non Operating IncomeOther Non Op Inc.
-0.08M0.03M0.01M-0.00M-0.04M0.03M-0.00M0.01M-0.01M0.01M0.01M0.01M-0.01M-1.20M0.08M1.93M-0.14M1.06M-1.58M-4.51M
Net income details
EBT
-1.09M-5.50M-1.24M1.25M0.16M-2.08M0.03M2.35M4.31M-9.99M-6.01M-9.59M-3.75M
Tax ProvisionsTaxes
0.19M-0.19M
Profit After TaxPAT
2.28M3.85M-3.54M2.09M2.27M-1.72M-1.52M-1.09M-5.50M-1.24M-0.43M0.17M0.57M0.04M1.99M3.78M-8.89M-5.42M-7.63M-1.73M
Income from Continuing OperationsIncome (Continuing)
-1.09M-5.50M-1.24M1.25M0.16M-2.08M0.03M2.35M4.13M-9.80M-6.01M-9.59M-3.75M
Consolidated Net IncomeConsol Net Inc.
-1.09M-5.50M-1.24M1.25M0.16M-2.08M0.03M2.35M4.13M-9.80M-6.01M-9.59M-3.75M
Income towards Parent CompanyParent Net Inc
-1.09M-5.50M-1.24M1.25M0.16M-2.08M0.03M2.35M4.13M-9.80M-6.01M-9.59M-3.75M
Net Income towards Common StockholdersNet Income
-1.09M-5.50M-1.24M1.25M0.16M-2.08M0.03M2.35M4.13M-9.80M-6.01M-9.59M-3.75M
Additional items
EPS (Basic)
-0.44-1.48-0.330.340.04-0.480.010.540.96-1.43-0.87-1.39-0.55
EPS (Diluted)
-0.44-1.48-0.330.340.04-0.480.010.540.96-2.27-1.39-2.22-0.87
Shares Outstanding
1.79M1.79M1.79M1.79M2.47M2.47M2.47M2.47M3.72M3.72M3.72M3.72M4.31M4.31M4.31M4.31M6.88M6.88M6.88M6.88M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
1.79M1.79M1.79M1.79M2.47M2.47M2.47M2.47M3.72M3.72M3.72M3.72M4.31M4.31M4.31M4.31M4.31M4.31M4.31M4.31M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
1.79M2.47M3.72M4.52M7.64M
EBITDA
-1.09M-5.50M-1.24M1.25M0.16M-2.08M0.03M2.35M4.31M-9.99M-6.01M-9.59M-3.75M
Tax Rate
4.31%1.88%